Publications
The Case for Manufacturing Drugs in the United States Goes Back 45 Years
June 9, 2025
The Bayh-Dole Act of 1980 requires inventions made wholly or in part with federal funding to be substantially manufactured in the United States. Asher M. Rubin and Cassidy A. Pomeroy-Carter discuss how the 1980 law intended to keep drug manufacturing in the United States.
Capabilities
Suggested News & Insights
Sidley Represents Sensei Biotherapeutics in Acquisition of Faeth TherapeuticsFebruary 18, 2026Sidley Represents Arsenal Capital Partners and MaxHealth in Sale of MaxHealth to CenterWellFebruary 17, 2026Sidley Represents Great Lakes In Its US$1.5 Billion Acquisition by SaltchukFebruary 11, 2026Legal Issues Arising From the Use of Artificial Intelligence in Drug DevelopmentFebruary 11, 2026Understanding Demands on Clients Helps Firms Give Turnkey AdviceFebruary 10, 2026Sidley Represents Optimas Solutions in the Carve-Out Sale of Its International BusinessFebruary 6, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory